| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $65.8M | +29.5% |
| Cost of Revenue | $71.1M | +20.3% |
| Gross Profit | -$5.3M | +36.1% |
| R&D Expense | $72.6M | +13.7% |
| SG&A Expense | $22.5M | -44.2% |
| Operating Income | -$113.8M | +30.7% |
| Pre-tax Income | -$102.7M | +33.0% |
| Income Tax | $108K | +86.2% |
| Net Income | -$102.8M | +33.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.3M | -62.4% |
| Accounts Receivable | $5.0M | -62.3% |
| Inventory | $8.1M | +206.3% |
| Current Assets | $94.3M | -54.0% |
| Total Assets | $113.8M | -47.5% |
| Current Liabilities | $33.0M | -21.1% |
| Total Liabilities | $43.5M | -39.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.9M | +2.7% |
| Investing Cash Flow | -$3.1M | +23.0% |
| Financing Cash Flow | $7.7M | -96.0% |
| Stockholders' Equity |
| $70.3M |
| -51.2% |